Precision Medicine: Key Trends, Regional Analysis and Market Forecasts 2022-2027

The Precision Medicine report provides a detailed evaluation of the technological advancements in the field of precision medicine and demand for precision medicine, including the adoption of precision medicine within both developing markets and established markets. In addition, this report, focusing on precision medicine initiatives, covers market opportunities; providing strategic insights into the technologies and key drivers that are pushing the space forward, and the role of key market players; 15 leading precision medicine vendors across the market.

This extensive research suite covering advances in precision medicine also contains a detailed dataset; providing forecasts for 60 countries across a number of different metrics, including the number of patients being tested for precision medicine purposes, the number of genetic tests carried out for precision medicine, the total number of precision medicine patients receiving personalised treatment, the total spend on precision medicine testing and treatment and total precision medicine revenue.

This precision medicine market report research suite comprises of:

• Strategy & Forecasts (PDF)
• 5-year Market Sizing & Forecast Spreadsheet (Excel)
• 12 Months Access to harvest Online Data Platform

Key Market Statistics

Market Size in 2022:

• $35.7bn

Market Size in 2027:

• $132.3bn

2022 to 2027 Spend Growth:

• 270%

Key Features

Market Dynamics: This section of the precision medicine study features strategic analysis of the major drivers, challenges, and innovations shaping the adoption and development of precision medicine, with key factors including the following market segmentation:

• COVID-19 pandemic impact on the precision medicine market
• Future strategic direction, market share and market outlook for precision medicine
• Key issues precision medicine vendors must be aware of surrounding legislation and data sharing

Regional Analysis: A regional market-level analysis of 16 countries, spanning 8 key regions within the healthcare infrastructure; covering the current deployment level of precision medicine applications and the future outlook of precision medicine in each market.
Key Takeaways & Strategic Recommendations: Analysis of a wide range of key development opportunities and major factors within the market for precision medicine in the healthcare industry, accompanied by key strategic recommendations for stakeholders.

Benchmark Industry Forecasts: Investigating lucrative growth of precision medicine market size in full; including forecasts for the total number of patients taking genetic tests for precision medicine, the total number of genetic tests carried out for precision medicine, total number of precision medicine patients receiving medical treatment options and precision medicine drugs, total spend on precision medicine test and treatment, and total precision medicine revenue. This precision medicine market growth data is split by our 8 key forecast regions and 60 countries:

North America:

• Canada, United States

Latin America:

• Argentina, Brazil, Chile, Colombia, Ecuador, Mexico, Peru, Uruguay

West Europe:

• Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, United Kingdom

Central & East Europe:

• Croatia, Czech Republic, Hungary, Poland, Romania, Russia, Turkey, Ukraine

Far East & China:

• China, Hong Kong, Japan, South Korea

Indian Subcontinent:

• Bangladesh, India, Nepal, Pakistan

Rest of Asia Pacific:

• Australia, Indonesia, Malaysia, New Zealand, Philippines, Singapore, Thailand, Vietnam

Africa & Middle East:

• Algeria, Egypt, Israel, Kenya, Kuwait, Nigeria, Qatar, Saudi Arabia, South Africa, United Arab Emirates

The Competitor Leaderboard: Key player capability and capacity assessment in the healthcare sector for 15 precision medicine vendors:

• Abbott Laboratories
• Almac Group Ltd
• AstraZeneca
• Asuragen Inc
• Biomérieux Sa
• Bristol-Myers Squibb
• Cepheid Inc
• Ge Healthcare
• IBM
• Illumina Inc
• Laboratory Corporation of America Holdings
• Novartis
• Qiagen
• Quest Diagnostics
• Thermo Fisher Scientific Inc.

Key Questions Answered

• How will key market trends affect projected precision medicine adoption?
• What technologies will accelerate precision medicine?
• Who are the leading vendors in the precision medicine market?
• What limitations are there holding back precision medicine?
• In which regions will precision medicine be most successful?

Key Market Forecast Splits

• Diagnosis
• Treatment

Metrics including the number of precision medicine patients, number of genetic tests carried out for precision medicine, total number of precision medicine patients receiving treatment, total spend on precision medicine test and treatment and total precision medicine revenue.

Geographical splits: 60 countries
Number of tables: Over 18 tables
Number of datapoints: Over 12,000 datapoints

Harvest: Our online data platform, harvest, contains the very latest market data and is updated throughout the year. This is a fully featured platform enabling clients to better understand key data trends and manipulate charts and tables; overlaying different forecasts within the one chart - using the comparison tool. Empower your business with our market intelligence centre, and receive alerts whenever your data is updated.

Interactive Excels (IFxl): Our IFxl tool enables clients to manipulate both forecast data and charts, within an Excel environment, to test their own assumptions using the interactive scenario tool and compare selected markets side by side in customised charts and tables. IFxls greatly increase a client’s ability to both understand a particular market and to integrate their own views into the model.